← Eichor
Study identifier: NCT07099651 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Autosomal Dominant Spinocerebellar Ataxias and Social Cognition

Condition: Autosomal Dominant Spinocerebellar Ataxia (SCA1, 2,3,6,7,27B)  ·  Sponsor: University Hospital, Angers

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersYes

About this study

Spinocerebellar ataxias are a group of rare neurodegenerative diseases, clinically and genetically highly heterogeneous, with an estimated mean prevalence of 2.7 per 100,000 population. The term "spinocerebellar ataxia" or "SCA" is often used for ataxias of genetic origin of autosomal dominant transmission, which are the subject of this study. Recent studies of social cognition in patients with genetic cerebellar pathologies, and autosomal dominant spinocerebellar ataxia in particular, are still few and far between (around 15 studies), and seem to highlight impairment of basic emotion recognition and theory of mind skills. That said, data have very often been collected on very small samples of patients (sometimes in case study format). They also remain contradictory, including in the examination of the cerebellar anatomoclinical correlates of the deficits. Thus, the question arises as to whether patients with spinocerebellar ataxia also show impairments in emotion recognition and cognitive and affective theory of mind in more ecologically valid dynamic and interactive assessment situations.

This description comes directly from the study's public registry record.

Talk to the study team

Philippe Allain, professor  ·  +33241355976  ·  phallain@chu-angers.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU AngersAngers, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07099651